Scarica l'app Stockscreener
7.50
3.10%
-0.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MYGN Giù?
Forum
Previsione
Frazionamento azionario
Myriad Genetics Inc Borsa (MYGN) Ultime notizie
Inspire Investing LLC Increases Holdings in Myriad Genetics, Inc. $MYGN - MarketBeat
Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage - MSN
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - TradingView
Myriad Genetics: How knowing genetic risks can help women with their healthcare - KATV
Is Myriad Genetics Inc. (MYD) stock considered safe havenWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Using RSI to spot recovery in Myriad Genetics Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
When is the best time to exit Myriad Genetics Inc.Market Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
Applying Elliott Wave Theory to Myriad Genetics Inc.Portfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
News impact scoring models applied to Myriad Genetics Inc.Oil Prices & Free Risk Controlled Daily Trade Plans - newser.com
Measuring Myriad Genetics Inc.’s beta against major indicesMarket Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV - The Manila Times
Dr. Stitt, Jodi Lavery discuss cancer screening fears, genetic testing benefits survey - KOKH
Myriad Genetics Finalizes CFO Separation Agreement - TipRanks
Myriad Genetics (NASDAQ:MYGN) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Public Employees Retirement System of Ohio Raises Position in Myriad Genetics, Inc. $MYGN - MarketBeat
Why Myriad Genetics Inc. stock is popular among millennialsEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Will Myriad Genetics Inc. (MYD) stock gain from lower interest ratesTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Will Myriad Genetics Inc. price bounce be sustainableJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Will Myriad Genetics Inc. (MYD) stock deliver stable dividendsCEO Change & Long-Term Capital Growth Strategies - newser.com
Is Myriad Genetics Inc. stock attractive for passive investorsJuly 2025 Action & Verified Swing Trading Watchlist - newser.com
Heatmap analysis for Myriad Genetics Inc. and competitorsJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
Is Myriad Genetics Inc. (MYD) stock ideal for retirement investorsPortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Should Dividend Investors Consider Tecil Chemicals and Hydro Power Ltd in 2025Automated Trading Signals & Create Passive Income With Smart Stocks - earlytimes.in
Myriad Genetics Inc Stock Analysis and ForecastDividend Stock Watch & Free Unlock Stock Analysis - earlytimes.in
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Myriad Genetics announces resignation of principal accounting officer - Investing.com
jscreen, TODAY Show & Mount Sinai Unite for Groundbreaking Cancer Genetic Screening Event in Honor of Breast Cancer Awareness Month - Yahoo Finance
United States Genomics Industryinvestments driving $115B - openPR.com
A Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack - The Globe and Mail
Myriad Genetics (NASDAQ:MYGN) Shares Down 5.2%Should You Sell? - MarketBeat
Is Myriad Genetics Inc a good long term investmentPortfolio Allocation Tips & Superior Capital Trading - Early Times
Assenagon Asset Management S.A. Buys 240,643 Shares of Myriad Genetics, Inc. $MYGN - MarketBeat
Myriad genetics lowers 2025 revenue guidance by $35M amid GeneSight challenges - MSN
Myriad Genetics and SOPHiA GENETICS partner on liquid biopsy test By Investing.com - Investing.com Canada
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - The Manila Times
0.17%
2.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):